What is the relative importance of cost-effectiveness information? Results from a Discrete Choice Experiment among Swedish medical decision makers. Sandra.

Slides:

Advertisements

Similar presentations

Swedish University of Agricultural Sciences Department of Forest Economics Who wins and who loses from increasing large carnivore stocks in Sweden? or.

Advertisements

We show that MP can be used to allocate resources to treatments within and between patient populations, using a policy-relevant example. The outcome is.

ECONOMIC ASSESSMENT OF IMPLEMENTATION TREATMENT GUIDELINES OF HYPERTENSION IN OUT-PATIENT PRACTICE Kulmagambetov IR Karaganda State Medical Academy, Kazakhstan.

Deductible-based Health Insurance Plans: Are Complex Deductible Exemptions Confusing Patients? Mary Reed, DrPH Center for Health Policy Studies, Kaiser.

Work motivation among healthcare professionals in the Saudi hospitals Presented by Nouf Sahal Al-Harbi Supervised by: Dr. Saad Al-Ghanim 2008.

Building Up a Real Sector Confidence Index for Turkey Ece Oral Dilara Ece Türknur Hamsici CBRT.

Pharmacy Program Initiatives Threshold, Mandatory Generic, Maximum Allowable Cost (MAC) Javier Menendez, RPh Pharmacy Manager Department of Medical Assistance.

Active Labour Market Policies for Disabled People:

Balancing efficiency and equity in formal economic evaluation of health care. Erik Nord, Senior Researcher, Norwegian Institute of Public Health, Professor.

Cost-Effectiveness Analyses in the UK - Lessons from the National Institute for Clinical Excellence Mark Sculpher Professor of Health Economics Centre.

The Cost-Effectiveness and Value of Information Associated with Biologic Drugs for the Treatment of Psoriatic Arthritis Y Bravo Vergel, N Hawkins, C Asseburg,

COST–EFFECTIVENESS ANALYSIS AND COST-UTILITY ANALYSIS

Decision Analysis as a Basis for Estimating Cost- Effectiveness: The Experience of the National Institute for Health and Clinical Excellence in the UK.

University of Southern California Department of Pharmaceutical Economics and Policy 1540 E. Alcazar Street, CHP 140 Los Angeles, CA

By Sanjay Kumar, Ph.D National Programme Officer (M&E), UNFPA – India

Transplantology in the Małopolska voivodship. Analysis of results from a pilot project conducted by the Statistical Office in Krakow. Anna Jasiówka Centre.

Budget Impact Analysis and Return on Investment Usa Chaikledkaew, Ph.D.

1 Health Status and The Retirement Decision Among the Early-Retirement-Age Population Shailesh Bhandari Economist Labor Force Statistics Branch Housing.

PROJECT Situation analysis and cost- effectiveness analysis of cervical cancer screening in Russia Coordinator of the project: N. Koroleva.

Clinical Pharmacy Basma Y. Kentab MSc..

The National Institute for Clinical Excellence in the UK – Experience and Impact Mark Sculpher Professor of Health Economics Centre for Health Economics.

Factors affecting contractors’ risk attitudes in construction projects: Case study from China 박병권.

A Deeper Understanding of Avery Fitness Center Customers

An investigation of factors moderating the relationship between job satisfaction and turnover intention among bank’s staff in Thailand By Warayu Thienpramuk.

Cost-Effectiveness Problem l You have a $1.5 billion budget to spend on any combination of these programs:

Centralized Non-Formulary Processing: Implementation of a CPRS “Reminder Dialog Template” Note to Request Restricted Drugs and Utilization of VISN 17 PBM.

DEVELOPING GLOBAL ROAD MAPS FOR REIMBURSEMENT PROCESSES USED IN HEALTH TECHNOLOGY ASSESSMENT: PHARMACEUTICALS, MEDICAL DEVICES, AND DIAGNOSTICS Noreen.

Pharmacoeconomics & Drug Compliance Dr Arif Hashmi.

The Use of Pharmacoeoconomics and Pharmacoepidemiology in Your Local MTF P&T Process by Marv Shepherd, Ph.D. Jim Wilson, Ph.D. Center for Pharmacoeconomic.

IN THE NAME OF GOD Flagship Course on Health Sector Reform and Sustainable Financing; Module 4: : How to construct.

The United Nations International Covenant on Civil and Political Rights: Does it make a difference in human rights behavior? By Linda Camp Keith Presented.

Incident reporting in the Swedish Consumer Price Index Martin Kullendorff, Oxana Tarassiouk Statistics Sweden Economic Statistics Department, Price Statistics.

HTA – Cost Containment or Quality Instrument? Bengt Jönsson Stockholm School of Economic.

Trends in Clinic Visits and Diagnosed C. trachomatis and N. gonorrhoeae Infections Following the Introduction of a Co-Pay in an STD Clinic C. Rietmeijer.

Cost-Effectiveness Thresholds Professor of Health Economics

BACKGROUND Cost-effectiveness of Psychotherapy for Cluster C Personality Disorders and the Value of Information and Implementation Djøra I. Soeteman 1,2,

Access to care Timely access to care Cost as a barrier to health care 1.

Understanding the Decision to Participate in a Survey and the Choice of the Response Mode Anders Holmberg and Boris Lorenc European Conference on Quality.

Maryland Department of Health and Mental Hygiene WB&A Market Research Executive Summary THE 2003 MARYLAND MEDICAID MANAGED CARE CUSTOMER SATISFACTION SURVEY.

OUT-OF-POCKET SPENDING ON TB AND HIV INFECTIONS IN MIDDLE- BELT, NIGERIA BY (1)UMEH, E.U., (2)UMEH, J.C. and (1)UDEH, L. (1)Dept. of Biological Sciences.

THE ORGANIZATIONAL COMMITMENT OF EMPLOYEES IN THE HOSPITALITY INDUSTRY: A CASE STUDY OF FIVE- STAR- HOTELS IN BANGKOK A Research Study Presented at the.

Meeting of the High Level Group on Administrative Burdens Dr. Johannes Ludewig Chairman of the Nationaler Normenkontrollrat Brussels, 23 July 2013.

GENDER SPECIFICITY AND GENDER BUDGETING IN BULGARIA: SOCIO AND ECONOMIC ASPECTS GENDER SPECIFICITY AND GENDER BUDGETING IN BULGARIA: SOCIO AND ECONOMIC.

Differences in the Quality of the Patient- Physician Relationship Among Terminally Ill African American and White Patients: Impact on Advance Care Planning.

Practice and Predictors of self-medication among urban and rural adults in Sri Lanka, three decades after Market Economic Reforms Dr. Pushpa Ranjan Wijesinghe.

Human costs of tobacco-related diseases * Marco Vannotti, France Priez, Claude Jeanrenaud, Jean-Pierre Zellweger Institut de recherches économiques et.

Using a Discrete Choice Experiment to Value the EQ-5D-5L in Canada Nick Bansback Assistant Professor School of Population and Public Health, University.

1 The Economics of Health Care and New Technologies Friday October 18, 2002 Between Technology and Humanity, Brussels Jan Busschbach PhD, –Department of.

Abstract This research was aimed to examine the requirement factors of entrepreneurs from graduates of Bachelor of Science and to compare those requirements.

A Prognosis For The Future Presented by: Karen W. Endresen, Ph.D. The Endresen Institute at The Jackson Organization Healthcare Marketing:

Pastors Report Mixed Economic Signs Survey of 1,000 Protestant Pastors.

Some sociological aspects on gender discrimination at work in Croatia Branka Galić Faculty of Humanities and Social Sciences, Department of sociology Zagreb,

Objectives of the Session By the end of this session, it will be hoped to achieve the following objectives;  To understand the nature and scope of managerial.

Summary and next step forward Ingemar Engström Professor of child and adolescent psychiatry Örebro University Member of the Nordic Committee of Bioethics.

Definition Title: Motivation and Attitude toward Integrated Instruction through Technology in College-level EFL Reading and Writing in Taiwan Integrated.

NATIONAL INITIATIVES: BEST PRACTICE AND LESSONS LEARNED FROM SCOTTISH EXPERIENCE Alan MacDonald Vice Chairman Scottish Medicines Consortium Hard Choices.

How to weight cost effectiveness in appraisal NVTAG / CVZ course: The appraisal process, work in progress 22th of April 2009 Jan van Busschbach.

IMPROVING ECONOMIC PRESCRIBING IN A TEACHING HOSPITAL THROUGH AN EDUCATIONAL STRATEGY TO PROMOTE GENERIC PRESCRIBING.

1 Information Systems Use Among Ohio Registered Nurses: Testing Validity and Reliability of Nursing Informatics Measurements Amany A. Abdrbo, RN, MSN,

 Leslie Abraham & Genna Fanelli.  Background  John Carroll University Initiative o Research Objectives o Methodology o Demographics o Data Collection.

Monday, June 23, 2008Slide 1 KSU Females prospective on Maternity Services in PHC Maternity Services in Primary Health Care Centers : The Females Perception.

Modernizing Health Care Inez Bartels.  Strong focus on the provision of health care  Institutions governing health care consumption control patients.

Determinants of Bahraini Women’s Empowerment Entisar Mohamed Ali Shaikh Mansoor Alsetri PhD in Politics RUW Conference on Women and Society April.

Cost effectiveness Analysis: Valuing Health; Valuing Research!

HEALTH ECONOMICS BASICS

Siriporn Poripussarakul, Mahidol University, Thailand

BACKGROUND AND OBJECTIVES

Professor of Health Economics

A PILOT STUDY EXAMINING CRITERIA USED TO SELECT DRUGS FOR HOSPITAL, PROVINCIAL AND NATIONAL FORMULARIES Robertson J, Newby DA, Pillay T, Walkom EJ The.

Presentation transcript:

What is the relative importance of cost-effectiveness information? Results from a Discrete Choice Experiment among Swedish medical decision makers. Sandra Erntoft (PhD) Project Manager The Swedish Institute for Health Economics (IHE) P.O. Box 2127, Lund

Background Previous research suggests that the relative importance of cost-effectiveness information varies between reimbursement-, formulary-, and prescribing - decisions. Little research has, however, investigated all three priority setting context simultanously… …and often used different methodologies and methods to investigate this question. Does the potential differences in the importance influence the threshold values of cost per QALY? 2

Purpose The purpose of the experiment was to investigate the relative importance of cost-effectiveness information (cost/QALY) compared with four other criteria; health status, expected size of medical effect, type of medical effect, budget impact, AND which values of a QALY are acceptable to the TLV, formulary committees and prescribing physicians? 3

Methods A sample of 996 questionnaires (TLV 53; formulary committee members 362; physicians 581). Previous study (Johnson & Backhouse 2006) and focus group consisting of 5 senior experts). 5 criteria – three reflecting need and two economics - 3 levels each. Two questions; A (ranking – ”forced choice”) and B (decision) in order to identify threshold values. 243 possible combinations or approx questions – main effects only + division into three blocks. Orthogonal design – iterative computer search algorithms in order to maximize D-efficiency. Conditional logit models. 4

Example of a D C question directed towards the TLV CriteriaTreatment ATreatment B The average health status in patient population High degree of pain/discomfort Low degree of pain/discomfort Type of medical effectIncreased QoLLife-sustainment Expected size of medical effect (effectiveness) Avoid loss of 1 QALYAvoid loss of 0.2 QALY Cost per QALY € € Budget Impact € per inhabitants € per inhabitants 5 A) Which treatment is better? (A is better, B is better) B) Which treatment do You think TLV should reimburse? (A, B, both A and B, neither A or B)

Formulas 6 A question (ranking): Uij=αpain*PAIN+αtype_eff*TYPE_EFF+αQALYgain*QALY_GAIN+αcost/QAL Y*COST_QALY+αbudg.imp.*BUDG_IMP B question (decision): V ij =βpain*PAIN+βtype eff* TYPE_EFF+ β QALYgain*QALY_GAIN+ β cost/QALY*COST_QALY+ β budg.imp.*BUDG_IMP

Descriptive statistics TLVForm. Com.Physicians Age (mean)52,254,947,3 Sex ( % males) Education: Physician Economist Lawyer Pharmacist Other/no answer N/a 17 HE education (% yes) Budget/ Operational responsibility (% yes)N/a Response rate: 21 %

Result 1: Relative importance when ranking pharmaceutical treatments 8

Result 2: Relative importance when making a decision 9

Result 3: Cost-effectiveness threshold values 41 cases of statistically significant differences between decision makers. In 28 cases the cost-effectiveness threshold values were lower rated by the TLV, than by formulary committee members and prescribing physicians. Cost per QALY TLV: Lowest € ; Highest €. Formulary committees: Lowest € ; Highest € Physicians: Lowest € ; Highest €. 1€ = 10,75 SEK (December 2009) ~ 1.3 U.S. $ 10

Discussion Cost-effectiveness information more important in reimbursement- than in formulary- and prescribing- decisions. Confirms results from previous research. Threshold values are lower in reimbursment- than in formulary- and prescribing decisions. Can this be explained by differences in educational backgrounds? Higher threshold values in Sweden than in for instance the Netherlands. Willingness to reimburse (WTR) rather than willingness to pay (WTP) – social utilities rather than individual utilities. The WTR is based on the relative value of the public program (the treatment option rejected) foregone. 11

Conclusions Both the relative importance of cost-effectiveness information and the threshold values of the cost/QALY varies between decision makers at national, regional and local level. The relatively high threshold values among formulary committee members and prescribing physicians may be a sign of a lack of social learning regarding the necessity of setting priorities due to scarce resources…. …or a result of the fact that priority setting is more difficult the closer the decision maker is to the patient. 12

Thank you for your attention! Sandra Erntoft Phone: